CRSP
Price
$41.86
Change
+$3.29 (+8.53%)
Updated
Jun 6 closing price
Capitalization
3.62B
63 days until earnings call
OTLK
Price
$1.90
Change
+$0.03 (+1.60%)
Updated
Jun 6 closing price
Capitalization
80.35M
Interact to see
Advertisement

CRSP vs OTLK

Header iconCRSP vs OTLK Comparison
Open Charts CRSP vs OTLKBanner chart's image
CRISPR Therapeutics AG
Price$41.86
Change+$3.29 (+8.53%)
Volume$4.73M
Capitalization3.62B
Outlook Therapeutics
Price$1.90
Change+$0.03 (+1.60%)
Volume$664.31K
Capitalization80.35M
CRSP vs OTLK Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. OTLK commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and OTLK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CRSP: $37.22 vs. OTLK: $1.63)
Brand notoriety: CRSP and OTLK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 76% vs. OTLK: 45%
Market capitalization -- CRSP: $3.33B vs. OTLK: $80.35M
CRSP [@Biotechnology] is valued at $3.33B. OTLK’s [@Biotechnology] market capitalization is $80.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileOTLK’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • OTLK’s FA Score: 0 green, 5 red.
According to our system of comparison, OTLK is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while OTLK’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 3 bearish.
  • OTLK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than OTLK.

Price Growth

CRSP (@Biotechnology) experienced а +0.64% price change this week, while OTLK (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.62B) has a higher market cap than OTLK($80.4M). CRSP YTD gains are higher at: -5.424 vs. OTLK (-13.757). OTLK has higher annual earnings (EBITDA): -83.38M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. OTLK (5.7M). OTLK has less debt than CRSP: OTLK (31M) vs CRSP (224M). CRSP has higher revenues than OTLK: CRSP (35M) vs OTLK (0).
CRSPOTLKCRSP / OTLK
Capitalization3.62B80.4M4,496%
EBITDA-447.31M-83.38M536%
Gain YTD-5.424-13.75739%
P/E RatioN/A0.46-
Revenue35M0-
Total Cash1.9B5.7M33,386%
Total Debt224M31M723%
FUNDAMENTALS RATINGS
CRSP vs OTLK: Fundamental Ratings
CRSP
OTLK
OUTLOOK RATING
1..100
776
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
8161
P/E GROWTH RATING
1..100
7761
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (65) in the Biotechnology industry is in the same range as OTLK (85). This means that CRSP’s stock grew similarly to OTLK’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OTLK (100). This means that CRSP’s stock grew similarly to OTLK’s over the last 12 months.

CRSP's SMR Rating (94) in the Biotechnology industry is in the same range as OTLK (100). This means that CRSP’s stock grew similarly to OTLK’s over the last 12 months.

OTLK's Price Growth Rating (61) in the Biotechnology industry is in the same range as CRSP (81). This means that OTLK’s stock grew similarly to CRSP’s over the last 12 months.

OTLK's P/E Growth Rating (61) in the Biotechnology industry is in the same range as CRSP (77). This means that OTLK’s stock grew similarly to CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPOTLK
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
89%
Momentum
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
75%
MACD
ODDS (%)
Bullish Trend 12 days ago
70%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 26 days ago
84%
Bearish Trend 19 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
83%
Bearish Trend 12 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.92%
RXRX - CRSP
72%
Closely correlated
+0.11%
BEAM - CRSP
72%
Closely correlated
-0.88%
NTLA - CRSP
69%
Closely correlated
+3.59%
ABCL - CRSP
62%
Loosely correlated
+3.03%
ALLO - CRSP
61%
Loosely correlated
+5.56%
More

OTLK and

Correlation & Price change

A.I.dvisor tells us that OTLK and MCRB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLK and MCRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+1.24%
MCRB - OTLK
32%
Poorly correlated
-2.49%
VIR - OTLK
31%
Poorly correlated
+2.15%
STRO - OTLK
30%
Poorly correlated
-3.03%
CRSP - OTLK
30%
Poorly correlated
-0.92%
ACXP - OTLK
29%
Poorly correlated
-1.52%
More